Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Phenomics Health Adds Clinical Assessment Capabilities
Making sure patients with multiple chronic conditions aren’t over- or under-dosed with medications can be a fraught process. Phenomics Health, based in Ann Arbor, Michigan, has been working on the genomics side of the problem. Its recent acquisition of Precera Bioscience’s patented portfolio of pharmacometabolomic technology adds capabilities to provide a more complete view of patients’ potential and actual response to medications than is currently available. Phenomics Health is a bioinformatics platform-based precision medicine company that uses artificial intelligence and machine learning to translate advanced genetic, epigenetic, multi-omics and health data into novel... Read More »
Health Care M&A Deals, Week Ending November 15, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care Acquirer Target Price Community Health Network Fairbanks N/A Discovery Behavioral Health Authentic Recovery Center N/A Biotechnology Acquirer Target Price Mesa Laboratories, Inc. Gyros Protein Technologies Holding AB $180,000,000 Foamix Pharmaceuticals... Read More »
PE Firms Trade WIRB-Copernicus for $3 Billion
Leonard Green & Partners, L.P won the auction to acquire WIRB-Copernicus Group (WCG) from Arsenal Capital Partners for $3 billion. The purchase value was originally reported in PE Hub Buyouts. WCG is a clinical services organization that enables biopharmaceutical companies, contract research organizations and institutions to accelerate the delivery of new treatments and therapies to patients. Arsenal will retain a stake in WCG. It acquired the company in March 2012 and led its recapitalization in August 2016 alongside other investors, including MSD Partners, the family office of Michael Dell. WCG has an estimated EBITDA of $175 million for 2019. WCG has been relatively quiet on the... Read More »
Welltower Shuffles Medical Office Building Portfolio
Welltower Inc. (NYSE: WELL), one of the largest diversified healthcare REITs, is mixing up its medical office building portfolio. Although Welltower is incredibly active in the Long-Term Care sector with its post-acute care facility portfolio, its MOB portfolio is worth highlighting. So far this year, the company has announced $3.5 billion worth of outpatient medical acquisitions. The most recent acquisition involves the purchase of a 29 Class-A medical office portfolio from Hammes Partners for $787 million. The portfolio totals 1.5 million square feet and has an average age of 10 years, with 12 years of weighted average lease term and 2.2% average annual rent increases. The... Read More »
Biogen Eyes Two Ophthalmic Biosimilars
Boston-based Biogen Inc. (NASDAQ: BIIB) has announced a “proposed transaction” with Samsung Bioepis Co., Ltd. to secure the exclusive rights to commercialize two new ophthalmology biosimilars, SB11 referencing Lucentis® and SB15 referencing Eylea®, in major markets worldwide, including the United States, Canada, Europe, Japan and Australia. In addition, Biogen will acquire exclusive commercialization rights for Samsung Bioepis’ anti-TNF portfolio, including Benepali (etanercept), Flixabi (infliximab) and Imraldi (adalimumab), in China. Biogen will also acquire an option to extend its existing commercial agreement with Samsung Bioepis for this anti-TNF portfolio in Europe.... Read More »
Telehealth Deals Pick Up in 2019
Digital health is hot, if deal volume is any measure (and we think it is). By mid-November, some 195 transactions are already on the books. That total is sure to surpass the 204 deals announced in all of 2018, which set a new record. In our DealSearchOnline database, the eHealth sector has grown in scope from simply electronic health records and revenue cycle management deals to include artificial intelligence and blockchain transactions in recent years. Telehealth has been around for some time, with the earliest deal in our database recorded in 2001. But the technology didn’t really take off, deal-wise, until 2016, when the number of deals rose to six. That doesn’t sound like... Read More »
Health Care M&A Deals, Week Ending November 8, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. eHealth Acquirer Target Price BV Investment Partners EDCO Health Information Solutions Inc. N/A Induction Healthcare Group PLC Horizon Strategic Partners Limited $3,211,900 American Well Aligned Telehealth, Inc. N/A Michigan Health Information Network Shared Services Great Lakes Health Connect N/A... Read More »
U.S. Hospital REIT Deals Surge in 2019
It’s become an accepted, almost expected, transaction. Privately held hospitals sell their real estate assets to a real estate investment trust (REIT) to get some fresh cash and to focus on operations rather than physical plants. Between 2009 and 2012, REIT deals for U.S. hospitals were announced once or twice a year. The number rose to six per year in 2013, 2015 and 2016 (just three in 2014). After two years of two or three deals annually (2017 and 2018), the number has already reached seven in 2019, with several weeks of deal making left in the year. The most recent deal was announced on November 5, as LifePoint Health agreed to sell the real estate assets of 10 unidentified... Read More »
Doc Group Deals Take Health Care in New Directions
With more than 180 deals announced so far in 2019, the Physician Medical Group sector is roaring toward another strong close. The usual specialties—dental, dermatology and ophthalmology—are still very active, but after 10 to 20 years of consolidation, their trajectories are flattening. Other specialties are gaining traction with private equity investors, particularly orthopedics, gastrointestinal (GI), urology, pain management and women’s health. Even ear, nose & throat (ENT) deals are picking up. We spoke with a few deal makers to find out where this sector stands at the end of 2019 and what’s ahead for M&A in 2020. The hot areas this year have been surgical subspecialties,... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
